Fickenscher James E - Insider Non-Derivative Transactions at Zynerba Pharmaceuticals, Inc. (ZYNE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Oct 10, 2023, Fickenscher James E's relationship to Zynerba Pharmaceuticals, Inc. (ZYNE) is Officer (Chief Financial Officer), and currently has 425,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ZYNE insiders.
Data Source: SEC.
Fickenscher James E - Insider Non-Derivative Transactions of ZYNE Common Stock
Fickenscher James E - Insider Non-Derivative Transactions at ZYNE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Oct 11, 2023 | U -- (Common Stock) | 425000 | 0 | 0 |
| Oct 11, 2023 | U -- (Common Stock) | 123087 | 0 | 255000 |
| Oct 11, 2023 | Acquisition -- (Common Stock) | 170000 | 0 | 425000 |
| Sep 14, 2023 | Sell -- (Common Stock) | 8998 | 1.33 | 378087 |
| Sep 13, 2023 | Acquisition -- (Common Stock) | 31200 | 0 | 387085 |
| Feb 9, 2023 | F -- (Common Stock) | 6544 | 0.6 | 355885 |
| Feb 8, 2023 | Acquisition -- (Common Stock) | 22547 | 0 | 362429 |
| Feb 2, 2023 | F -- (Common Stock) | 5927 | 0.6 | 339882 |
| Feb 1, 2023 | Acquisition -- (Common Stock) | 21073 | 0 | 345809 |
| Jan 25, 2023 | Acquisition -- (Common Stock) | 170000 | 0 | 324736 |
| Jan 24, 2023 | Sell -- (Common Stock) | 17769 | 0.6 | 154736 |